GB0606426D0 - Benzimidazole derivatives - Google Patents

Benzimidazole derivatives

Info

Publication number
GB0606426D0
GB0606426D0 GBGB0606426.5A GB0606426A GB0606426D0 GB 0606426 D0 GB0606426 D0 GB 0606426D0 GB 0606426 A GB0606426 A GB 0606426A GB 0606426 D0 GB0606426 D0 GB 0606426D0
Authority
GB
United Kingdom
Prior art keywords
benzimidazole derivatives
benzimidazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0606426.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0606426.5A priority Critical patent/GB0606426D0/en
Publication of GB0606426D0 publication Critical patent/GB0606426D0/en
Priority to RU2008142831/04A priority patent/RU2008142831A/ru
Priority to PE2007000352A priority patent/PE20071149A1/es
Priority to EP07723708A priority patent/EP2004629A2/en
Priority to CA002644380A priority patent/CA2644380A1/en
Priority to CNA2007800087520A priority patent/CN101400669A/zh
Priority to JP2009501943A priority patent/JP2009531363A/ja
Priority to KR1020087023787A priority patent/KR20080110769A/ko
Priority to ARP070101297A priority patent/AR060334A1/es
Priority to AU2007234021A priority patent/AU2007234021B2/en
Priority to BRPI0710180-5A priority patent/BRPI0710180A2/pt
Priority to PCT/EP2007/002763 priority patent/WO2007112913A2/en
Priority to MX2008012403A priority patent/MX2008012403A/es
Priority to US12/295,381 priority patent/US20100227889A1/en
Priority to CL200700850A priority patent/CL2007000850A1/es
Priority to TW096111055A priority patent/TW200806647A/zh
Priority to ZA200806833A priority patent/ZA200806833B/xx
Priority to CR10199A priority patent/CR10199A/es
Priority to IL193475A priority patent/IL193475A0/en
Priority to TNP2008000369A priority patent/TNSN08369A1/en
Priority to GT200800200A priority patent/GT200800200A/es
Priority to EC2008008781A priority patent/ECSP088781A/es
Priority to MA31302A priority patent/MA30341B1/fr
Priority to NO20084543A priority patent/NO20084543L/no
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
GBGB0606426.5A 2006-03-30 2006-03-30 Benzimidazole derivatives Ceased GB0606426D0 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
GBGB0606426.5A GB0606426D0 (en) 2006-03-30 2006-03-30 Benzimidazole derivatives
US12/295,381 US20100227889A1 (en) 2006-03-30 2007-03-28 Benzimidazole Derivatives
BRPI0710180-5A BRPI0710180A2 (pt) 2006-03-30 2007-03-28 derivados de benzimidazol
MX2008012403A MX2008012403A (es) 2006-03-30 2007-03-28 Derivados de benzimidazol.
EP07723708A EP2004629A2 (en) 2006-03-30 2007-03-28 Benzimidazole derivatives
CA002644380A CA2644380A1 (en) 2006-03-30 2007-03-28 Benzimidazole derivatives
CNA2007800087520A CN101400669A (zh) 2006-03-30 2007-03-28 苯并咪唑衍生物
JP2009501943A JP2009531363A (ja) 2006-03-30 2007-03-28 ベンズイミダゾール誘導体
KR1020087023787A KR20080110769A (ko) 2006-03-30 2007-03-28 벤즈이미다졸 유도체
ARP070101297A AR060334A1 (es) 2006-03-30 2007-03-28 Derivados de benzimidazol
AU2007234021A AU2007234021B2 (en) 2006-03-30 2007-03-28 Benzimidazole derivatives
RU2008142831/04A RU2008142831A (ru) 2006-03-30 2007-03-28 Производные бензимидазола
PCT/EP2007/002763 WO2007112913A2 (en) 2006-03-30 2007-03-28 Benzimidazole derivatives
PE2007000352A PE20071149A1 (es) 2006-03-30 2007-03-28 Derivados de benzimidazol
TW096111055A TW200806647A (en) 2006-03-30 2007-03-29 Benzimidazole derivatives
CL200700850A CL2007000850A1 (es) 2006-03-30 2007-03-29 Compuestos derivados de benzimidazol; procedimiento de preparacion; composicion farmaceutica; y uso para prevenir o tratar condiciones de huesos asociadas con la reduccion fuerte o resorcion incrementada de calcio.
ZA200806833A ZA200806833B (en) 2006-03-30 2008-08-07 Benzimidazole derivatives
CR10199A CR10199A (es) 2006-03-30 2008-08-11 Derivados de benzimidazol
IL193475A IL193475A0 (en) 2006-03-30 2008-08-14 Benzimidazole derivatives
TNP2008000369A TNSN08369A1 (en) 2006-03-30 2008-09-22 Benzimidazole derivatives
GT200800200A GT200800200A (es) 2006-03-30 2008-09-29 Derivados de benzimidazol
EC2008008781A ECSP088781A (es) 2006-03-30 2008-09-30 Derivados de benzimidazol
MA31302A MA30341B1 (fr) 2006-03-30 2008-10-17 Dérivés de benzimidazole
NO20084543A NO20084543L (no) 2006-03-30 2008-10-28 Benzimidazolderivater

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0606426.5A GB0606426D0 (en) 2006-03-30 2006-03-30 Benzimidazole derivatives

Publications (1)

Publication Number Publication Date
GB0606426D0 true GB0606426D0 (en) 2006-05-10

Family

ID=36424926

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0606426.5A Ceased GB0606426D0 (en) 2006-03-30 2006-03-30 Benzimidazole derivatives

Country Status (24)

Country Link
US (1) US20100227889A1 (enExample)
EP (1) EP2004629A2 (enExample)
JP (1) JP2009531363A (enExample)
KR (1) KR20080110769A (enExample)
CN (1) CN101400669A (enExample)
AR (1) AR060334A1 (enExample)
AU (1) AU2007234021B2 (enExample)
BR (1) BRPI0710180A2 (enExample)
CA (1) CA2644380A1 (enExample)
CL (1) CL2007000850A1 (enExample)
CR (1) CR10199A (enExample)
EC (1) ECSP088781A (enExample)
GB (1) GB0606426D0 (enExample)
GT (1) GT200800200A (enExample)
IL (1) IL193475A0 (enExample)
MA (1) MA30341B1 (enExample)
MX (1) MX2008012403A (enExample)
NO (1) NO20084543L (enExample)
PE (1) PE20071149A1 (enExample)
RU (1) RU2008142831A (enExample)
TN (1) TNSN08369A1 (enExample)
TW (1) TW200806647A (enExample)
WO (1) WO2007112913A2 (enExample)
ZA (1) ZA200806833B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1993559T1 (sl) 2006-02-03 2017-01-31 Opko Renal, Llc Zdravljenje nezadostnosti in pomanjkanja vitamina D s 25-hidroksivitaminon D2 in 25-hidroksivitaminom D3
PT2679228T (pt) 2006-06-21 2018-04-16 Opko Ireland Global Holdings Ltd Terapia utilizando um agente de repleção de vitamina d e um agente de substituição hormonal de vitamina d
CN104257667B (zh) 2007-04-25 2019-06-04 欧普科Ip 控股Ii 有限公司 治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的方法和组合物
KR101959952B1 (ko) 2007-04-25 2019-03-19 사이토크로마 인코포레이티드 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
ES2783980T3 (es) 2010-03-29 2020-09-21 Opko Ireland Global Holdings Ltd Métodos y composiciones para la reducción de niveles de paratiroides
EP2643298A1 (en) * 2010-11-26 2013-10-02 Leo Pharma A/S Substituted cyclopentyl - azines as casr- active compounds
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
MY198547A (en) 2016-03-28 2023-09-04 Opko Ireland Global Holdings Ltd Methods of vitamin d treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000026430A (ja) * 1998-07-02 2000-01-25 Taisho Pharmaceut Co Ltd ２、５、６−置換ベンズイミダゾール化合物誘導体
US6362202B1 (en) * 1999-03-02 2002-03-26 Sepracor Inc. Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
WO2004041277A1 (en) * 2002-11-01 2004-05-21 Merck & Co., Inc. Carbonylamino-benzimidazole derivatives as androgen receptor modulators
GB0400781D0 (en) * 2004-01-14 2004-02-18 Novartis Ag Organic compounds
EP1964548A1 (en) * 2007-03-02 2008-09-03 Novartis AG Pharmaceutical compositions comprising a calcilytic agent

Also Published As

Publication number Publication date
AU2007234021A1 (en) 2007-10-11
WO2007112913A3 (en) 2007-12-21
TNSN08369A1 (en) 2009-12-29
WO2007112913A2 (en) 2007-10-11
CA2644380A1 (en) 2007-10-11
US20100227889A1 (en) 2010-09-09
IL193475A0 (en) 2009-05-04
JP2009531363A (ja) 2009-09-03
AU2007234021B2 (en) 2011-04-28
TW200806647A (en) 2008-02-01
GT200800200A (es) 2008-11-10
BRPI0710180A2 (pt) 2011-08-09
CN101400669A (zh) 2009-04-01
PE20071149A1 (es) 2007-12-04
CR10199A (es) 2008-10-16
MA30341B1 (fr) 2009-04-01
KR20080110769A (ko) 2008-12-19
AR060334A1 (es) 2008-06-11
CL2007000850A1 (es) 2008-03-14
NO20084543L (no) 2008-10-21
RU2008142831A (ru) 2010-05-10
MX2008012403A (es) 2008-10-07
ECSP088781A (es) 2008-10-31
ZA200806833B (en) 2009-05-27
EP2004629A2 (en) 2008-12-24

Similar Documents

Publication Publication Date Title
HUS2000031I1 (hu) Benzimidazol-származékok
IL194367A0 (en) Dihydropyrazolopyrimidinone derivatives
ZA200901336B (en) Pyridizinone derivatives
IL193641A0 (en) Spiroindolinone derivatives
IL195013A0 (en) Pyridopyrimidinone derivatives
IL198319A0 (en) Spiroindolinone derivatives
IL195422A0 (en) 2-pyrazinecarboxamide derivatives
ZA200805574B (en) Indol-3-yl-carbonyl-spiro-piperidine derivatives
IL198059A0 (en) 2-aminocarbonyl-pyridine derivatives
IL196364A0 (en) Aminoindazolylurea derivatives
IL193211A0 (en) Indazole-heteroaryl derivatives
IL198645A0 (en) 5-hydroxymethyl-oxazolidin-2-one derivatives
IL197152A0 (en) 5-phenyl-nicotinamide derivatives
IL193475A0 (en) Benzimidazole derivatives
EP2133347A4 (en) 1-BIARYLAZETIDINONDERIVATE
EP2172454A4 (en) benzimidazole derivative
ZA200807460B (en) Spiroindolinone derivatives
IL197239A0 (en) Phenyloxyaniline derivatives
ZA200908626B (en) Benzimidazole Derivatives
HK1125375A (en) Benzimidazole derivatives
IL198973A0 (en) Sulfamatobenzothiophene derivatives
GB0610018D0 (en) Benzotriazepinone derivatives
GB0610019D0 (en) Benzotriazepinone derivatives
ZA200903280B (en) 2-aminocarbonyl-pyridine derivatives
AP2009005065A0 (en) Sulfonyl-quinoline derivatives

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)